Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1035 | 958 | 1122 | 993 | 1164 | 2098 |
Fund Return | 3.5% | -4.18% | 12.17% | -0.23% | 3.08% | 7.69% |
Place in category | 771 | 763 | 756 | 386 | 408 | 134 |
% in Category | 76 | 76 | 80 | 58 | 88 | 45 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -5.26 | - | ||
FIM Emerging markets ESG | 392.72M | 8.19 | 0.58 | 4.34 | ||
S SaastOrahasto Kohtuullinen | 306.4M | 10.17 | 2.99 | 5.77 | ||
S-Saastorahasto Rohkea | 278.62M | 13.42 | 4.85 | 8.14 | ||
FIM USA | 260.69M | 20.98 | 9.59 | 11.81 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife T | 549.43K | 13.52 | 6.57 | 11.43 | ||
Danske Invest MediLife K | 89.01M | 13.52 | 6.56 | 11.42 | ||
Seligson Global Top 25 Pharmac B | 271.45M | 7.05 | 7.62 | 7.36 | ||
Seligson Co Global Top 25 Pharma A | 271.45M | 7.05 | 7.62 | 7.33 | ||
LahiTapiola Hyvinvointi B | 133.66M | 3.50 | -0.23 | 7.69 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.14 | 749.92 | -0.46% | |
Novo Nordisk B | DK0062498333 | 5.51 | 721.8 | -2.21% | |
AbbVie | US00287Y1091 | 4.77 | 171.73 | +2.37% | |
Amgen | US0311621009 | 3.75 | 289.90 | +0.71% | |
Stryker | US8636671013 | 3.44 | 390.14 | +1.16% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review